相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitochondrial content and hepcidin are increased in obese pregnant mothers
G. M. Anelli et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2018)
Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver Disease
Tatsuya Yamada et al.
CELL METABOLISM (2018)
Activation of the porcine alveolar macrophages via toll-like receptor 4/NF-kappa B mediated pathway provides a mechanism of resistin leading to inflammation
Bi Li et al.
CYTOKINE (2018)
MiR-34a regulates mitochondrial content and fat ectopic deposition induced by resistin through the AMPK/PPAR alpha pathway in HepG2 cells
Fengyun Wen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Mitochondria-related transcriptional signature is downregulated in adipocytes in obesity: a study of young healthy MZ twins
Sini Heinonen et al.
DIABETOLOGIA (2017)
Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-κB signaling pathways: implications for intervertebral disc degeneration
Z. Li et al.
OSTEOARTHRITIS AND CARTILAGE (2017)
EXPRESSION OF RESISTIN IN THE LIVER OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Piotr Gierej et al.
POLISH JOURNAL OF PATHOLOGY (2017)
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children
David E. Kleiner et al.
CLINICS IN LIVER DISEASE (2016)
Metabolic aspects of adult patients with nonalcoholic fatty liver disease
Ludovico Abenavoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human Monocytes
Sahmin Lee et al.
CELL METABOLISM (2014)
Alcoholic and non-alcoholic steatohepatitis
Manuela G. Neuman et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
Pediatric non-alcoholic steatohepatitis: The first report on the ultrastructure of hepatocyte mitochondria
Joanna M. Lotowska et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
Ludovico Abenavoli et al.
REVIEWS ON RECENT CLINICAL TRIALS (2014)
Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways
Ana-Maria Gan et al.
CELL AND TISSUE RESEARCH (2013)
Central Resistin Overexposure Induces Insulin Resistance Through Toll-Like Receptor 4
Yacir Benomar et al.
DIABETES (2013)
Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway
Lei Zhou et al.
HEPATOLOGY (2013)
Mouse Resistin Modulates Adipogenesis and Glucose Uptake in 3T3-L1 Preadipocytes Through the ROR1 Receptor
Beatriz Sanchez-Solana et al.
MOLECULAR ENDOCRINOLOGY (2012)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
An Isoform of Decorin Is a Resistin Receptor on the Surface of Adipose Progenitor Cells
Alexes C. Daquinag et al.
CELL STEM CELL (2011)
Resistin competes with lipopolysaccharide for binding to toll-like receptor 4
Andrej Tarkowski et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels
Ling-Ling Jiang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice
Neel S. Singhal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke
Stamatis P. Efstathiou et al.
CLINICA CHIMICA ACTA (2007)
Serum resistin and hepatic fat content in nondiabetic individuals
Gianluca Perseghin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance
Matthias J. Bahr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Role of adiponectin in human skeletal muscle bioenergetics
Anthony E. Civitarese et al.
CELL METABOLISM (2006)
Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases
E Yagmur et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance
C Pagano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance
Ancha Baranova et al.
OBESITY SURGERY (2006)
Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway
N Silswal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
NASH: a mitochondrial disease
D Pessayre et al.
JOURNAL OF HEPATOLOGY (2005)
Resistin, an adipokine with potent proinflammatory properties
M Bokarewa et al.
JOURNAL OF IMMUNOLOGY (2005)
Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance
JA Ibdah et al.
GASTROENTEROLOGY (2005)
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
VB Ritov et al.
DIABETES (2005)
Regulation of fasted blood glucose by resistin
RR Banerjee et al.
SCIENCE (2004)
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes
KF Petersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines:: Relationships in obesity
J Vendrell et al.
OBESITY RESEARCH (2004)
Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients
M Bajaj et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Megamitochondria formation - physiology and pathology
T Wakabayashi
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation
KH Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The hormone resistin links obesity to diabetes
CM Steppan et al.
NATURE (2001)
分享论文
